Publication: Contribution of M-1 and M-2 muscarinic receptor subtypes to convulsions in fasted mice treated with scopolamine and given food
| dc.contributor.author | AYDIN OMAY, BANU | |
| dc.contributor.authors | Bacanak, Merve Saygi; Aydin, Banu; Cabadak, Hulya; Nurten, Asiye; Goren, Mehmet Zafer; Enginar, Nurhan | |
| dc.date.accessioned | 2022-03-12T22:38:51Z | |
| dc.date.available | 2022-03-12T22:38:51Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Treatment of fasted mice and rats with the nonselective muscarinic antagonist, scopolamine or atropine, causes convulsions after food intake. This study evaluated the effect of fasting on the expression of M-1 and M-2 muscarinic receptors in the brain regions, the relationship between receptor expression and seizure stages, and the muscarinic receptor subtype which plays a role in the occurrence of convulsions. Mice were grouped as allowed to eat ad lib (fed) and deprived of food for 24 h (fasted). Fasted animals developed convulsions after being treated with scopolamine (60%) or the selective M-1 receptor antagonist pirenzepine (10 mg/kg; 20% and 60 mg/kg; 70%) and given food. Fasting increased expression of M-1 receptors in the frontal cortex and M-2 receptors in the hippocampus, but produced no change in the expression of both receptors in the amygdaloid complex. Food intake after fasting decreased M-1 receptor expression in the frontal cortex and M-1 and M-2 receptor expression in the hippocampus. Seizure severity was uncorrelated with muscarinic receptor expression in the brain regions. Taken together, these findings provide evidence for the role of M-1 muscarinic receptor antagonism and fasting-induced increases in M-1 and M-2 expression possible underlying mechanism in the occurrence of convulsions in fasted animals. | |
| dc.identifier.doi | 10.1016/j.bbr.2017.11.018 | |
| dc.identifier.eissn | 1872-7549 | |
| dc.identifier.issn | 0166-4328 | |
| dc.identifier.pubmed | 29158113 | |
| dc.identifier.uri | https://hdl.handle.net/11424/235735 | |
| dc.identifier.wos | WOS:000463130800046 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE BV | |
| dc.relation.ispartof | BEHAVIOURAL BRAIN RESEARCH | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Fasting | |
| dc.subject | Convulsion | |
| dc.subject | M-1 muscarinic receptor expression | |
| dc.subject | M-2 muscarinic receptor expression | |
| dc.subject | Scopolamine | |
| dc.subject | Pirenzepine | |
| dc.subject | Food intake | |
| dc.subject | ACETYLCHOLINE-RELEASE | |
| dc.subject | CHOLINERGIC MODULATION | |
| dc.subject | BASOLATERAL AMYGDALA | |
| dc.subject | CEREBRAL-CORTEX | |
| dc.subject | SEIZURES | |
| dc.subject | BRAIN | |
| dc.subject | M1 | |
| dc.subject | LOCALIZATION | |
| dc.subject | EXPRESSION | |
| dc.subject | NUCLEUS | |
| dc.title | Contribution of M-1 and M-2 muscarinic receptor subtypes to convulsions in fasted mice treated with scopolamine and given food | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| local.avesis.id | 578cb647-5f91-46f3-96a6-3858daaf1c56 | |
| local.import.package | SS17 | |
| local.indexed.at | WOS | |
| local.indexed.at | SCOPUS | |
| local.indexed.at | PUBMED | |
| local.journal.numberofpages | 8 | |
| local.journal.quartile | Q2 | |
| oaire.citation.endPage | 430 | |
| oaire.citation.startPage | 423 | |
| oaire.citation.title | BEHAVIOURAL BRAIN RESEARCH | |
| oaire.citation.volume | 364 | |
| relation.isAuthorOfPublication | af9e48cc-cef6-4af2-bdb7-5b424aadfc2b | |
| relation.isAuthorOfPublication.latestForDiscovery | af9e48cc-cef6-4af2-bdb7-5b424aadfc2b |